CD274 and neoplasm: These cases provide evidence of the significance of tumor molecular analysis and the substantial support it can offer when combined with the results of immunotherapy predictive biomarkers, such as PD-L1 expression and TMB, to improve the accuracy of ICI response prediction in individual patients.